DOCS
Doximity Inc
NYSE: DOCS · HEALTHCARE · HEALTH INFORMATION SERVICES
$21.63
+0.89% today
Updated 2026-07-29
Market cap
$3.87B
P/E ratio
21.96
P/S ratio
6.00x
EPS (TTM)
$0.98
Dividend yield
—
52W range
$17 – $77
Volume
3.5M
WallStSmart proprietary scores
62
out of 100
Grade: C+
Hold
Investment rating
5.3
Growth
C+8.5
Quality
A8.5
Profitability
A8.0
Valuation
A3/9
Piotroski F-Score
Weak
5.4
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$24.56
+13.55%
12-Month target
$24.30
+12.34%
Intrinsic (DCF)
$51.64
Margin of safety
+49.73%
5 Strong Buy4 Buy12 Hold0 Sell1 Strong Sell
Price chart
Stock snapshot
Strengths
+ Altman Z 5.39 — safe zone
+ Profit margin 30.40% — above average
+ ROE 20.62% — strong efficiency
+ Free cash flow $107.27M — positive
+ 49.73% below intrinsic value
Risks
- Piotroski 3/9 — weak financial health
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2023 | 2024 | 2025 | 2026 | TTM |
|---|---|---|---|---|---|
| Revenue | $419.05M | $475.42M | $570.40M | $644.86M | $644.86M |
| Net income | $112.82M | $147.58M | $223.19M | $196.05M | $19.11M |
| EPS | — | — | — | — | $0.98 |
| Free cash flow | $173.42M | $178.29M | $266.74M | $317.50M | $107.27M |
| Profit margin | 26.92% | 31.04% | 39.13% | 30.40% | 30.40% |
Peer comparison
Smart narrative
Doximity Inc trades at $21.63. representing a P/E of 21.96x trailing earnings. Our Smart Value Score of 62/100 indicates the stock is good. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 5.39, it sits in the safe zone. TTM revenue stands at $644.86M. with profit margins at 30.40%. Our DCF model estimates intrinsic value at $51.64.
Frequently asked questions
What is Doximity Inc's stock price?
Doximity Inc (DOCS) trades at $21.63, on a P/E of 22.0x and a P/S of 6.0x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Doximity Inc overvalued?
Doximity Inc carries a Smart Value Score of 62/100 (Grade C+), which we rate Hold. That score blends growth, quality, and valuation into one read. Our DCF puts intrinsic value at $51.64 versus the $21.63 price, a 49.7% margin of safety on a cash flow basis.
What is the price target of Doximity Inc (DOCS)?
The 12-month analyst consensus target is $24.56, about 13.5% above the current $21.63. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the intrinsic value of Doximity Inc (DOCS)?
Our DCF model estimates intrinsic value at $51.64, a +49.7% margin of safety versus today's $21.63. Intrinsic value is what the projected cash flows are worth today. A positive reading means the price sits below that estimate, leaving a cushion if growth holds.
What is Doximity Inc's revenue?
Doximity Inc's trailing twelve-month revenue is $644.86M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Doximity Inc's Altman Z-Score is 5.39, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryHEALTH INFORMATION SERVICES
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio6.00x
ROE20.62%
Beta1.29
50D MA$21.38
200D MA$36.01
Shares out0.13B
Float0.13B
Short ratio—
Avg volume3.5M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—